| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/11/2010 | US20100063105 Pharmaceutical uses and synthesis of nicotinanilide-n-oxides |
| 03/11/2010 | US20100063095 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 03/11/2010 | US20100063094 Methods for treatment of colorectal cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 03/11/2010 | US20100063088 Raf Kinase Inhibitors |
| 03/11/2010 | US20100063083 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the treatment of cancer |
| 03/11/2010 | US20100063082 Camptothecin derivatives with antitumor activity |
| 03/11/2010 | US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators |
| 03/11/2010 | US20100063074 Cancer Treatment Method |
| 03/11/2010 | US20100063073 Methods and Compositions Utilizing Quinazolinones |
| 03/11/2010 | US20100063072 Solid forms of pemetrexed |
| 03/11/2010 | US20100063067 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/11/2010 | US20100063066 Raf inhibitor compounds and methods of use thereof |
| 03/11/2010 | US20100063057 Compositions and methods for delivery of anti-cancer agents |
| 03/11/2010 | US20100063054 cMET INHIBITORS |
| 03/11/2010 | US20100063053 Heterocyclic inhibitors of mek and methods of use thereof |
| 03/11/2010 | US20100063049 2-carbocycloamino-4-imidazolylpyrimidines as agents for the inhbition of cell proliferation |
| 03/11/2010 | US20100063046 Tetracyclic imidazole analogs |
| 03/11/2010 | US20100063043 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics |
| 03/11/2010 | US20100063038 Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis |
| 03/11/2010 | US20100063034 Conjugated psychotropic drugs and uses thereof |
| 03/11/2010 | US20100063031 Kinase inhibitor compounds |
| 03/11/2010 | US20100063028 Triazabenzo[E]Azulene Derivatives for the Treatment Of Tumors |
| 03/11/2010 | US20100063025 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of RHO-Kinase |
| 03/11/2010 | US20100063024 Dihydropyrazolopyrimidinone Derivatives |
| 03/11/2010 | US20100063010 Method for administering a spill resistant pharmaceutical system |
| 03/11/2010 | US20100062999 Composition extracted from shark cartilage marrow |
| 03/11/2010 | US20100062996 Dioxolane derivates for the treatment of cancer |
| 03/11/2010 | US20100062993 Adenosine Nucleotides as Dietary Supplements and as Agents in the Prevention of Cancer and the Metastasis Thereof |
| 03/11/2010 | US20100062992 Salts of 5-Azacytidine |
| 03/11/2010 | US20100062990 Novel pseudoglycolipid and use thereof |
| 03/11/2010 | US20100062978 Method for inhibiting signal transduction, signal transduction inhibitor to be used therein and use thereof |
| 03/11/2010 | US20100062968 Novel strategies for delivery of active agents using micelles and particles |
| 03/11/2010 | US20100062468 Methods and products related to low molecular weight heparin |
| 03/11/2010 | US20100062443 Using myeloblastosis oncogene expression profile as tool in detection of cell proliferative disorders associated with respiratory system |
| 03/11/2010 | US20100062143 Method and device for radiotherapy |
| 03/11/2010 | US20100062084 Treatment Of Gastrointestinal Diseases |
| 03/11/2010 | US20100062079 Polymorphisms predictive of platinum-coordinating complex induced ototoxicity |
| 03/11/2010 | US20100062078 Pharmaceutical composition for treating cancer and the signaling pathway thereof |
| 03/11/2010 | US20100062056 Encapsulated picoplatin |
| 03/11/2010 | US20100062055 Lipid-based nitric oxide donors |
| 03/11/2010 | US20100062053 Cholestanol derivative for combined use |
| 03/11/2010 | US20100062049 Aqueous formulation for selective targeting and delivering gene to cancer cells |
| 03/11/2010 | US20100062047 Composition for Administration to Mammals or Human |
| 03/11/2010 | US20100062020 Method of Treating a Malignancy in a Subject Via Direct Picornaviral-Mediated Oncolysis |
| 03/11/2010 | US20100062013 Cancer antigen peptides derived from wt1 |
| 03/11/2010 | US20100062012 Negative Genetic Regulation of Cancer Cell Renewal in Synergy with Notch- or Numb-Specific Immunotherapy |
| 03/11/2010 | US20100062010 Novel peptide compound |
| 03/11/2010 | US20100062008 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 03/11/2010 | US20100062007 Multi-modal cancer therapy using viral hitch-hiking |
| 03/11/2010 | US20100062003 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 03/11/2010 | US20100062002 Brain Endothelial Cell Expression Patterns |
| 03/11/2010 | US20100062001 Antibodies for selective apoptosis of cells |
| 03/11/2010 | US20100062000 Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations |
| 03/11/2010 | US20100061996 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 03/11/2010 | US20100061994 Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 03/11/2010 | US20100061992 Therapeutic uses of tim-3 modulators |
| 03/11/2010 | US20100061988 Monoclonal antibodies |
| 03/11/2010 | US20100061985 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 03/11/2010 | US20100061981 p75NTR MEDIATES EPHRIN-A REVERSE SIGNALING |
| 03/11/2010 | US20100061979 Modified soluble fgf receptor fc fusions wsith improved biological activity |
| 03/11/2010 | US20100061978 Methods for detecting and treating cancer |
| 03/11/2010 | US20100061977 Methods and compositions for treating and diagnosing diseases |
| 03/11/2010 | US20100061975 Uses for 4,17B-dihydroxyandrost-4-ene-3-one |
| 03/11/2010 | US20100061974 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency |
| 03/11/2010 | US20100061961 Recombinant super-compound interferon |
| 03/11/2010 | US20100061958 Modulation of Regulatory T Cells by Human IL-18 |
| 03/11/2010 | US20100061942 Compositions and Methods for Modulating Store-Operated Calcium Entry |
| 03/11/2010 | US20100061933 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 03/11/2010 | US20100061932 Peptides useful as cell-penetrating peptides |
| 03/11/2010 | US20100061929 Neoplasia targeting peptides and methods of using the same |
| 03/11/2010 | US20100061928 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 03/11/2010 | CA2738034A1 Materials and methods for inhibiting cancer cell invasion related to fgfr4 |
| 03/11/2010 | CA2736306A1 Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors |
| 03/11/2010 | CA2736275A1 Alfa-carboline inhibitors of npm-alk, ret, and bcr-abl |
| 03/11/2010 | CA2735859A1 2, 4-disulfonyl pheny tert-butyl nitrone for the treatment of gliomas |
| 03/11/2010 | CA2735823A1 Use of a truncated eif-5a1 polynucleotide to induce apoptosis in cancer cells |
| 03/11/2010 | CA2735806A1 Aminotriazolopyridines and their use as kinase inhibitors |
| 03/11/2010 | CA2735782A1 Heterocyclic pim-kinase inhibitors |
| 03/11/2010 | CA2735420A1 Macrocyclic pyrimidines as protein kinase inhibitors |
| 03/11/2010 | CA2734908A1 Compositions of pd-1 antagonists and methods of use |
| 03/11/2010 | CA2734905A1 Multispecific antibodies |
| 03/11/2010 | CA2734682A1 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
| 03/11/2010 | CA2734523A1 Methods and compositions for the treatment of cancer |
| 03/11/2010 | CA2734415A1 Picolinamide derivatives as kinase inhibitors |
| 03/11/2010 | CA2734125A1 Platinum complex and medical compound containing same |
| 03/10/2010 | EP2161338A1 Isolated mammalian monocyte cell genes; related reagents |
| 03/10/2010 | EP2161286A1 Antibodies |
| 03/10/2010 | EP2161280A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications |
| 03/10/2010 | EP2161271A1 Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl |
| 03/10/2010 | EP2161024A1 Combination product for the treatment of cancer |
| 03/10/2010 | EP2161023A2 Anti-angiogenic agents and methods of use. |
| 03/10/2010 | EP2160470A2 Chimeric pufa polyketide synthase systems and uses thereof |
| 03/10/2010 | EP2160465A1 Tumour growth inhibitory compounds and methods of their use |
| 03/10/2010 | EP2160409A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors |
| 03/10/2010 | EP2160406A1 Antibodies useful for therapy and diagnosis of cancer |
| 03/10/2010 | EP2160200A1 Antibody-light fusion products for cancer therapeutics |
| 03/10/2010 | EP1641474B1 Therapeutical composition containing dentritic cells and use thereof |
| 03/10/2010 | EP1605964B1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE |
| 03/10/2010 | EP1511752B3 Camptothecins with a modified lactone ring |
| 03/10/2010 | EP1023315B1 Methods and compositions for destruction of selected proteins |